Cellaria, BioLamina partner on new cell culture models

By The Science Advisory Board staff writers

February 11, 2021 -- Cellaria and BioLamina have announced that they plan to collaborate on developing new cell culture models for cancer research, tissue modeling, drug screening, and research in basic and regenerative medicine.

The two firms will develop cell reprogramming methods, large-scale induced pluripotent stem cell (iPSC) expansions, and lineage differentiation for human cells and animal cells for vertebrate and nonvertebrate species, Cellaria said.

Cellaria makes cell models, while BioLamina provides human recombinant laminin, which is used to generate and expand iPSCs.

Fujifilm invests $2B on cell culture manufacturing
Fujifilm plans to invest more than $2 billion to build a large-scale cell culture manufacturing site for biopharmaceuticals in the U.S.
Plastics manufacturer produces new cell culture microfilm
Toyoda Gosei, a manufacturer of rubber and plastic automotive components, has developed a urethane microfoam film for cell culture that allows cells to...
PHC, On-chip Biotech partner on cell culture applications
PHC and On-chip Biotechnologies are partnering to deliver total cell culturing solutions for researchers and organizations across a wide range of applications.
Cellaria introduces new models to study pancreatic cancer
Cellaria has launched three new cell lines for pancreatic cancer that it hopes will improve patient care by improving the value of in vitro methods of...
Stem cell findings help researchers learn about early-onset Parkinson's
New research utilizing stem cells indicates that the metabolic processes that lead to young-onset Parkinson's disease could begin years before symptoms...

Copyright © 2021 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter